Comparative Efficacy of Flow Diverter Devices in the Treatment of Carotid Sidewall Intracranial Aneurysms: a Retrospective, Multicenter Study
Adam A. Dmytriw,Hamza Adel Salim,Basel Musmar,Nicole M. Cancelliere,Christoph J. Griessenauer,Robert W. Regenhardt,Jesse Jones,Vincent Tutino,Zuha Hasan,Nicola Limbucci,Sovann V. Lay,Julian Spears,James D. Rabinov,Mark R. Harrigan,Adnan H. Siddiqui,Elad I. Levy,Christopher J. Stapleton,Leonardo Renieri,Christophe Cognard,Hamza Shaikh,Anna Luisa Kühn,Markus A. Möhlenbruch,Stavropoula I. Tjoumakaris,Pascal Jabbour,Philipp Taussky,Fabio Settecase,Manraj K. S. Heran,Anh Nguyen,David Volders,Pablo Harker,Diego A. Devia,Ajit S. Puri,Marios Psychogios,Juan C. Puentes,Giuseppe Leone,Giuseppe Buono,Margherita Tarantino,Mario Muto,Francesco Briganti,Shamsher Dalal,Vamsi Gontu,Rodolfo E. Alcedo Guardia,Juan C. Vicenty-Padilla,Patrick Brouwer,Matthias H. Schmidt,Clemens Schirmer,Gwynedd E. Pickett,Tommy Andersson,Michael Söderman,Thomas R. Marotta,Hugo Cuellar-Saenz,Ajith J. Thomas,Aman B. Patel,Vitor Mendes Pereira,Nimer Adeeb,Flow diversion Multinational Observational cohort Device comparsion (FlowMOD) Investigators
DOI: https://doi.org/10.1007/s00062-024-01435-x
2024-07-19
Clinical Neuroradiology
Abstract:The comparative efficacy and safety of first-generation flow diverters (FDs), Pipeline Embolization Device (PED) (Medtronic, Irvine, California), Silk (Balt Extrusion, Montmorency, France), Flow Re-direction Endoluminal Device (FRED) (Microvention, Tustin, California), and Surpass Streamline (Stryker Neurovascular, Fremont, California), is not directly established and largely inferred.
radiology, nuclear medicine & medical imaging,clinical neurology